While it may have been a chaotic year for the US Food and Drug Administration (FDA) due to layoffs, leadership changes and ...

Japanese biotech Nxera Pharma (TSE: 4565) has revealed that Germany’s Boehringer Ingelheim opted not to exercise its ...

Danish clinical-stage techbio Evaxion today revealed it has been informed that MSD (tradename of Merck & Co outside the USA ...

The US president has signed an Executive Order directing federal agencies to move more quickly toward rescheduling marijuana ...

Iceland-based biosimilars developer Alvotech and a US affiliate of Israel’s Teva Pharmaceutical Industries, today announced ...

Syremis Therapeutics, a Tel Aviv, Israel, and Boston, USA-based clinical-stage biopharma developing novel medicines to make a ...

US radioisotope producer Niowave has expanded its supply agreement with British pharma AstraZeneca (LSE: AZN) to a 10-year ...

Orum Therapeutics, a Korea-listed biotech developing degrader-antibody conjugates (DACs), has secured 145 billion South ...

South Korean biosimilars specialist Celltrion said the European medicines regulator has adopted a positive opinion for an autoinjector version of SteQeyma, its biosimilar to Stelara (ustekinumab).

The USA’s Coalition for Epidemic Preparedness Innovations (CEPI) will invest up to $54.3 million to support a pivotal Phase III clinical trial that aims to help advance Moderna’s investigational ...

Shares of Amicus Therapeutics shot up 30% to $10.89 in pre-market activity today, on the news of a takeover offer from fellow USA-based BioMarin.

US precision allosteric therapeutics company Atavistik Bio has raised a $120 million Series B financing.